[Taylor&Francis] Safety of JAK inhibitors: focus on cardiovascular and thromboembolic events

osmozc Post time 2024-5-10 15:06:04 | Show all posts |Read mode
Reward100points

journal£ºExpert Review of Clinical Immunology

Authors£ºFabiola Atzeni; Calin D. Popa; Valeria Nucera; Michael T. Nurmohamed

Published date£º2022-3-4

DOI£º10.1080/1744666x.2022.2039630

PDF link£ºhttps://www.tandfonline.com/doi/pdf/10.1080/1744666X.2022.2039630

Article link£ºhttp://dx.doi.org/10.1080/1744666x.2022.2039630

Article Source£ºInforma UK Limited¡£


Remark£º

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
rivoon Post time 2024-5-10 15:06:05 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    2495

Latest Reply

Return to the list